iTonic Holdings Ltd (ITOC) stock

ITOCNasdaqElectromedical & Electrotherapeutic Apparatus

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026Score 6/30

$1.98+0.08 (+4.21%)

Close on Nov 13, 2026Market cap $33.76MP/E –Yield –

iTonic r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $459.14K, up 392.0% from the year before.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$459.14K	+392.0%
FY2024	Dec 31, 2024	$93.32K	+10.5%
FY2023	Dec 31, 2023	$84.47K	+14.6%
FY2022	Dec 31, 2022	$73.72K	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ITOC.

Revenue growth16.7% · median 55.9%

Gross margin62.6% · median 39.2%

Operating margin-991.7% · median -643.0%

Net margin-974.7% · median -642.0%

Advertisement
300 × 250

See a number that looks wrong?